Iyuzeh (latanoprost 0.005% ophthalmic solution) — Medica

Initial criteria

• Patient has ocular hypertension OR open-angle glaucoma (including normal-tension glaucoma).

Reauthorization criteria

• Same as initial criteria.

Approval duration

1 year